Atlas Trials

Association Between RVT and Prognosis After Neoadjuvant Targeted Therapy in EGFR NSCLC

Clinical trial NCT06771960 · RECRUITING

Trial details

NCT number
NCT06771960
Sponsor
Guangdong Provincial People's Hospital
Status
RECRUITING
Study type
OBSERVATIONAL
Lung Cancer (NSCLC)
Start date
2025-02-01
Primary completion
2025-12-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.